Filters

Showing 25–48 of 52 results

Please add widgets to the WooCommerce Filters widget area in Appearance > Widgets

25-48 of 52 products

  • Sample release reagent

    Brief

    Sample release reagent developed based on the Sansure one-tube fast release technology platform. Adopting Sansure patent nucleic acid release technology, can quickly lyse pathogens at room temperature, no need heating, centrifuging or replacing tubes, the sample DNA/RNA can be extracted quickly through simple operations.   Sample Release Reagent is used for the pretreatment of nucleic acids, to release the nucleic acids from specimens, then the released nucleic acids can be used for clinical in vitro diagnosis or used for the detection through equipment.

    Parameters

    Qualification CE

    Kit components

    No. Product Name Spec.
    S1011E Sample Release Reagent 48T/kit
    S1013E Sample Release Reagent 48T/kit
    S1014E Sample Release Reagent 24T/Kit, 48T/kit
  • S3053E EV/EV71/CA16 – Enterovirus/Coxsackievirus A16/Enterovirus 71 RNA Diagnostic Kit

    Brief

    Hand-foot-and-mouth disease is a common childhood disease caused by enteroviruses. Most of the patients will have a fever and get vesicle rash in the mouth or on the hand and foot. A few patients will get cephalomeningitis, cerebritis, neurogenic pulmonary edema and myocarditis, etc. Some patients may get sequelae of this disease or even death. The viruses that can cause hand-foot-and-mouth disease include Coxsackievirus, new-type enterovirus and ECHO virus, of which the most common types are Coxsackievirus A16 and Enterovirus 71. The laboratory diagnosis methods mainly include virus isolation, nucleic acid detection, etc.   The Enterovirus/Coxsackievirus A16/Enterovirus 71 RNA Diagnostic Kit (PCR-Fluorescence Probing) is intended to detect Enterovirus, Coxsackievirus A16 and Enterovirus 71 in throat swab by applying real-time quantitative PCR technique. The detection results can be used to distinguish Coxsackievirus A16 and Enterovirus 71.

    Parameters

    Product features Parameter
    Specimen Type throat swab
    Technical Platform Advanced magnetic beads technology
    Target pathogen EV, EV71, CA16
    Internal Control Lentivirus
    PCR Instrument ABI7500,SLAN-96P
    Amplification Time 100 min
    Sensitivity 1000 copies/mL
    Spec. 24T
    Qualification CE
  • S3014E HCMV – Human Cytomegalovirus DNA Quantitative Fluorescence Diagnostic Kit

    Brief

    Human cytomegalovirus (HCMV), also called cell inclusion body virus, is a double helix DNA virus and belongs to β genus of herpes virus family, which causes infected cells to enlarge and has a huge intranuclear inclusion. The ways of infection of HCMV is mainly through contact, blood transfusion, intrauterine and birth canal, and the infections are commonly found in fetus, newborns, pregnant women, etc. If the pregnant women are infected, it may cause their newborns congenital monstrosity. When the organism immune deficiency or immune system is under inhibitory state, people can be easily infected by HCMV, such as the patients receiving immunosuppressive therapy after transplantation of organ, the patients receiving malignant tumor chemotherapy and AIDS patients, etc. If these patients are infected by HCMV, it usually causes high mortality and serious diseases.   Clinical tests suggest that HCMV infection hasn’t specific manifestations and it causes harm to multiple organs, especially the liver and lung. A statistical analysis of positive and negative rate of HCMV in various kinds of clinical indications shows HCMV infection is probably related with various diseases, such as Cytomegalovirus hepatitis, Infant hepatitis syndrome, liver dysfunction, pneumonia, Bronchitis, Upper respiratory tract infections, enteritis, enterocolitis, diarrhea, hematemesis, heart failure, etc.   The Human Cytomegalovirus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the detection of HCMV DNA in human urine, serum and peripheral blood samples. It is intended for use as an aid in the diagnosis of an HCMV infection and for observing drug efficacy.

    Parameters

    Product features Parameter
    Specimen Type urine, serum, and peripheral blood.
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Target pathogen HCMV
    Internal Control cloning plasmid
    PCR Instrument ABI7500, Roche LC 480 and Stratagene Mx3000P
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T
    Qualification CE
  • S3015E EBV-Epstein-Barr virus DNA Quantitative Fluorescence Diagnostic Kit

    Brief

    Epstein-barr virus (EBV) is known to be the first virus that is definitely related with human tumors. EBV infection mainly causes infectious mononucleosis in children and tumor-related diseases such as Burkitt’s lymphoma, lymphoid tissue hyperplasia in immunocompromised individuals, primary lymphoma, empyema associated lymphoma, T-cell lymphoma, NK cell lymphoma/leukemia, Hodgkin’s disease, nasopharyngeal carcinoma, stomach cancer, lymphoid epithelial tissue cancer, smooth muscle tumors, etc.   The Epstein-Barr virus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the quantification of Epstein-Barr Virus (EBV) DNA in peripheral blood. Test result can be used as an aid in the diagnosis of an EBV infection and in observation of drug efficacy.

    Parameters

    Product features Parameter
    Specimen Type peripheral blood.
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Target pathogen EBV
    Internal Control cloning plasmid
    PCR Instrument ABI7500, Roche LC 480 and Stratagene Mx3000P
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T
    Qualification CE
  • C003E BCI – Nucleic Acid Test Kit for HBV, HCV, HIV (Type1+2)

    Brief

    Nucleic Acid Test Kit for HBV, HCV, HIV (Type1+2), is based on real-time fluorescence PCR technology and used for nucleic acid qualitative detection of HBV, HCV, HIV1+2 in plasma.   This kit is intended for use as a blood donor screening test to detect HBV DNA, HCV RNA, HIV-1 RNA and HIV-2 RNA in pooled or individual sample from healthy blood donors, blood donors of various components (red blood cells, platelets and plasma) and other types of blood donors. All plasma to be tested can be screened as individual samples or tested in pools after mixing with each equal aliquots according to routine serological screening results HBV, HCV and HIV samples. For the pooled sample showed positive test results, carry out individual testing, the individual test result should be used as the final test result of this sample. The test results of this diagnostic kit can distinguish reactivity of between HBV, HCV and HIV.

    Advantages

    High sensitivity
    • HBV 3IU/mL
    • HCV 10IU/mL
    • HIV 45IU/mL
    High efficiency
    • 576 tests/ 5h(pooling)
    • 45 tests / 4.5h(single
    Complete subtypes coverage
    • HBV A-H
    • HCV 1-6
    • HIV-1(M/N/O)and HIV-2
    Single pipe joint inspection
    • Four tests for a tube of samples
    • Direct discriminating positive
    Automated detection
    • Extraction and amplification process
    • No need to be on duty
    Cost and space savings
    • One extractor + one amplifier
    • Less consumable material consumption

    Features

    Sample preparation and extraction in one module Fully automatic sample preparation and nucleic acid extraction in one module to build up a integrated reaction system   Flexible testing mode 6 pooling sample testing or individual donor testing (IDT) supported   Advanced magnetic beads technology Nanometer-level beads enable beads-in-PCR amplification ensuring maximum nucleic acid template   Patented magnetic beads lateral suction technology Thorough waste liquid removal allows minimal magnetic beads loss   Sophisticated sample information processing Automatic recognition of the sample barcode & sample tracking and archiving table generation available   High throughput 558/45 samples result output in one time   Minimal system maintenance time Less than 20 minutes startup with fewer maintenance tasks   Excellent accuracy A total number of 105,124 blood bags which confirmed as negative by serological testing were tested against some referential screening kits. 15 false-negative results in reference tests were found.

    Parameters

    Qualification CE
  • S3034E HCV Genotype – Hepatitis C Virus Genotype Diagnostic Kit

    Brief

    By applying real-time PCR technology, the Hepatitis C Virus Genotype Diagnostic Kit (PCR-Fluorescence Probing) is designed for qualitative identification of HCV genotypes (including genotypes 1b, 1, 2, 3, 4, 5 and 6) from HCV RNA positive samples. The test results can be used as an aid in the identification of HCV genotypes and determination of an appropriate therapeutic treatment indicated for the above listed gentoypes. The results can be used only for clinical reference, and cannot be used as the only evidence for adjusting therapeutic drugs. Clinical symptoms and other laboratory test results should also be considered to comprehensively determine the patients treatment.

    Parameters

    Product features Parameter
    Specimen Type serum
    Extraction Platform Magnetic beads technologies
    Genotype 1b, 1(1b, 1a), 2 (2a), 3 (3a, 3b), 4 (4a), 5 (5a), 6 (6a)
    Internal Control Plasmid
    PCR Instrument Mx3000P,Slan 96P
    Sensitivity 1000 IU/mL
    Spec. 12T
    Qualification CE
  • S3119E HCV Ultra – Hepatitis C Virus RNA Quantitative Fluorescence Diagnostic Kit

    Brief

    Hepatitis C Virus RNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the quantification of HCV RNA in human serum or plasma. It is intended for use as an aid in the diagnosis of an HCV infection and observing drug efficacy. Hepatitis C is mainly caused by HCV infection and transmitted through blood. Chronic infection of HCV can lead to chronic inflammation of liver and fibrosis, and some patients may develop into liver cirrhosis, even Hepatocellular Carcinoma (HCC). It has huge harms on patients’ health and life quality, and has become a severe social and public health issue.

    Parameters

    Product features Parameter
    Specimen Type Plasma
    Extraction Platform Advanced magnetic beads technology
    Genotype HCV 1-6 genotype
    Internal Control Lentivirus particles
    PCR Instrument SLAN-96P, ABI7500, Roche cobas 480
    Sensitivity 12 IU/mL
    Linear range 25—1.0E+08 IU/mL
    Spec. 24T
    Qualification CE
  • S3013E HBV fast – Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit

    Brief

    Hepatitis B Viral (HBV) DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the quantification of HBV DNA in human serum or plasma. It can be used to evaluate antiviral treatment and monitor the therapeutic effect by monitoring HBV DNA baseline levels and changes in patient blood. Test results should not be taken as the only indicator for evaluation of diseases, but to be combined with patients clinical symptoms and other laboratory tests to analyze the diseases.

    Parameters

    Product features Parameter
    Specimen Type Serum or plasma
    Extraction Platform One-tube fast test release
    Genotype HBV genotype A-H
    Internal Control Plasmid
    Compatible Instrument ABI7300 , Stratagene Mx3000P , Roche Light Cycler 480 , ABI7500, SLAN-96P and QuantStudio 5
    Sensitivity 30 IU/mL
    Linear range 100—5.0E+09 IU/mL
    Spec. 24T, 48T
    Qualification CE
  • S3118E HBV Ultra – Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit

    Brief

    Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing)  (HBV Ultra) is an in vitro nucleic acid amplification test for the quantification of Human HBV DNA in human serum. It is intended for use as an aid in diagnosing an HBV infection and observing drug efficacy.

    Performance

    Advanced magnetic beads technology HBV DNA detection and viral load measurement are essential for treatment decisions and patient monitoring. Sansure's HBV Ultra uses the advanced magnetic beads technology to extract HBV DNA from clinical Plasma.  Our technology achieved high sensitivity and wide linear range detection to meet of clinical diagnosis and follow-up needs.   Highly conservative primer probe design Sansure primers and probes target select the highly conservative S gene of HBV, which can cover A-H genotypes and avoid missed detection.   High-efficient quality control system HBV Ultra uses UNG enzyme + dUTP system to remove carry-over contamination to avoid a false positive result.   HBV Ultra uses Internal Control HBV Ultra uses Internal Control is the full name to whole-process the HBV extraction and amplification process to avoid false negative results.

    Parameters

    Product features Parameter
    Specimen Type Plasma
    Extraction Platform Advanced magnetic beads technology
    Genotype HBV genotype A-H
    Internal Control Pseudoviruses
    PCR Instrument SLAN-96P, ABI7500, Roche cobas 480
    Sensitivity 5 IU/mL
    Linear range 20—2.0E+09 IU/mL
    Spec. 48T
    Qualification CE
  • S3017E HPV 6,11 – Human papillomavirus (Type 6 and 11) DNA Fluorescence Diagnostic Kit

    Brief

    HPV (Type 6 and 11) DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the detection of low-risk HPV (type 6/11) DNA in reproductive tract secretions. It is intended for use as an aid in the diagnosis of an HPV (type 6/11) infection and patients with clinically suspected genital warts.

    Parameters

    Product features Parameter
    Specimen Type reproductive tract secretions
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Detection types type 6, 11
    Internal Control β--globin gene
    PCR Instrument ABI7500,QuantStudio 5, Stratagene Mx3000P, MA-6000, SLAN-96P, LightCycler® 480 II,iPonatic S-Q31A&B,S-Q36A
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T, 12-P
    Qualification CE
  • S3019E HPV 16, 18 – Human papillomavirus (Type 16 and 18) DNA Fluorescence Diagnostic Kit

    Brief

    HPV (Type 16 and 18) DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the detection of high-risk HPV (Type 16 and 18) DNA in reproductive tract secretions. It is intended for use as an aid in the diagnosis of an HPV (Type 16 and 18) infection, and the early screening of cervical cancer.

    Parameters

    Product features Parameter
    Specimen Type reproductive tract secretions
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Detection types type 16, 18
    Internal Control β--globin gene
    PCR Instrument ABI7500,QuantStudio 5, Stratagene Mx3000P, MA-6000, SLAN-96P, LightCycler® 480 II,iPonatic S-Q31A&B,S-Q36A
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T, 12-P
    Qualification CE
  • S3360E HPV 15HR – 15 High-risk Human Papillomavirus Nucleic Acid Diagnostic Kit

    Brief

    15 High-risk HPV DNA Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the detection of high-risk HPV (type 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) present in exfoliated cells from females’ cervix. The test results can be used as an aid in the diagnosis of a high-risk HPV infection.

    Parameters

    Product features Parameter
    Specimen Type exfoliated cells from females’ cervix
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Detection types type 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68
    Internal Control β--globin gene
    PCR Instrument ABI7500, QuantStudio 5, MA-6000, SLAN-96P, LightCycler 480, Stratagene Mx3000P, iPonatic S-Q31A&B,S-Q36A
    Amplification Time 70 min
    Sensitivity 1000 copies/mL
    Spec. 48T, 12-P
    Qualification CE
  • S3027E HPV G15 – High-risk Human Papillomavirus DNA (Genotype) Diagnostic Kit

    Brief

    This High-risk HPV DNA (Genotype) Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the detection of high-risk HPV (type 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) present in exfoliated cells from females’ cervix. The test results can be used for identification of HPV genotypes.

    Parameters

    Product features Parameter
    Specimen Type Exfoliated cells from females’ cervix
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Detection types type 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68
    Internal Control β--globin gene
    PCR Instrument SLAN-96P, ABI 7500, Roche LC 480 and QuantStudioTM 5 , Stratagene Mx3000P
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 24T/48T
    Qualification CE
  • S3057E HPV 13+2 – Human Papillomavirus DNA Diagnostic Kit

    Brief

    Base on the study results by WHO International Agency for Research on Cancer (IARC) and other international organizations, the 13 kinds of genotypes including HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 are classified as high-risk HPV, and the 5 kinds of genotypes including HPV26, 53, 66, 73, 82 are classified as medium-risk HPV.   Human Papillomavirus DNA Diagnostic Kit (PCR-Fluorescence Probing) chooses the above 13 kinds of high-risk genotypes and two popular kinds of medium-risk genotypes that are HPV 53 and 66 to be the target genotypes, in order to guarantee that the kit is capable of cervical carcinoma screening and risk evaluation. Moreover, it is clearly indicated that the females at the age of 30 or above who have no abnormal cervical cytology but the HPV detection is positive, especially for HPV16 and HPV18 infected females, should get vaginoscopy immediately. Therefore, the diagnostic kit can be used for detection of the 15 kinds of target genotypes and also subtype identification of HPV16 and HPV18.

    Parameters

    Product features Parameter
    Specimen Type Exfoliated cells from females’ cervix
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Detection types Type 16+18+31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68
    Internal Control β--globin gene
    PCR Instrument ABI7500, MA-6000, SLAN-96P, QuantGene 9600 , iPonatic S-Q31A&B, S-Q36A
    Amplification Time 70 min
    Sensitivity 1000 copies/mL
    Spec. 48T,  24-P
    Qualification CE
  • S3002E HSV-2 – Herpes Simplex Virus Type 2 DNA Fluorescence Diagnostic Kit

    Brief

    Herpes Simplex Virus Type 2 (HSV-2) DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is used to detect the presence of HSV-2- DNA in samples such as male urethral swab and female cervical swab. The detection result can be used as an aid in the diagnosis of an HSV-2 infection. The test provides a molecular diagnostics-based solution for early diagnosis of venereal disease and for preliminary screening of high-risk venereal disease groups.

    Parameters

    Product features Parameter
    Specimen Type Genital tract secretions.
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Target pathogen HSV-2
    Internal Control Recombinant plasmid
    PCR Instrument ABI7500,QuantStudio 5, Stratagene Mx3000P, MA-6000, SLAN-96P, LightCycler® 480 II,iPonatic S-Q31A&B,S-Q36A
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T, 12-P
    Qualification CE
  • S3004E UU – Ureaplasma Urealyticum DNA Fluorescence Diagnostic Kit

    Brief

    The Ureaplasma Urealyticum (UU) DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is used to detect the presence of UU-DNA in samples such as male urethra swab and female cervical swab. The detection result can be used as an aid in the diagnosis of a UU infection. The test provides a molecular diagnostics-based solution for early diagnosis of venereal disease and for preliminary screening of high-risk venereal disease groups.

    Parameters

    Product features Parameter
    Specimen Type Genital tract secretions.
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Target pathogen UU
    Internal Control Recombinant plasmid
    PCR Instrument ABI7500,QuantStudio 5, Stratagene Mx3000P, MA-6000, SLAN-96P, LightCycler® 480 II,iPonatic S-Q31A&B,S-Q36A
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T, 12-P
    Qualification CE
  • S3003E NG – Neisseria Gonorrhoeae DNA Fluorescence Diagnostic Kit

    Brief

    Neisseria Gonorrhoeae (NG) DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is used to detect the presence of NG-DNA in samples such as male urethral swab and female cervical swab. The detection result can be used as an aid in the diagnosis of an NG infection. The test provides a molecular diagnostics-based solution for early diagnosis of venereal disease and for preliminary screening of high-risk venereal disease groups.

    Parameters

    Product features Parameter
    Specimen Type Genital tract secretions.
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Target pathogen NG
    Internal Control Recombinant plasmid
    PCR Instrument ABI7500, QuantStudio 5, Stratagene Mx3000P, MA-6000, SLAN-96P, LightCycler® 480 II, iPonatic S-Q31A&B, S-Q36A
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T, 12-P
    Qualification CE
  • S3016E MP – Mycoplasma Pneumoniae DNA Fluorescence Diagnostic Kit

    Brief

    Mycoplasma pneumoniae (MP) is a pathogenic microorganism between bacteria and virus. It is mainly transmitted through buccal and nasal mucus by the air causing respiratory diseases, with the highest incidence in children and adolescents. Respiratory infection has the manifestations of pharyngitis and bronchitis, with a few cases causing infection to the lung. Recently, incidence among infants and children is increasing, therefore, early diagnosis and treatment can decrease the exacerbation of acute pneumonia in children. The development of molecular biology also draws more attention to the fluorescence quantitative PCR technology for the detection of MP-DNA.   This diagnostic kit is an in vitro nucleic acid amplification test for the detection of mycoplasma pneumoniae DNA in humansputum and throat swab. It is intended for use as an aid in the diagnosis of an MP infection and providing a molecular-diagnostics-based solution.

    Parameters

    Product features Parameter
    Specimen Type Sputum and throat swab
    Extraction Platform One-tube fast release technology
    Internal Control cloning plasmid containing the target gene fragment
    PCR Instrument ABI 7500, SLAN-96P,MA-6000, Roche LightCycler 480, iPonatic S-Q31A&B,S-Q36A
    Sensitivity 400 copies/mL
    Spec. 48T, 12-P
    Qualification CE
  • S3001E CT – Chlamydia Trachomatis DNA Fluorescence Diagnostic Kit

    Brief

    Chlamydia Trachomatis (CT) DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) applies to detect CT DNA in specimens like reproductive tract secretion. The detection result can be used for aiding diagnosis of CT infection, which provides molecular diagnosis base for early diagnosis of venereal disease and for preliminary screening of venereal disease high-risk groups.

    Parameters

    Product features Parameter
    Specimen Type genital tract secretions.
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Target pathogen CT
    Internal Control Recombinant plasmid
    PCR Instrument ABI 7500, Roche LC480,Stratagene Mx3000P
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T
    Qualification CE
  • S3050E CT/UU/NG – Chlamydia Trachomatis/Ureaplasma Urealyticum/Neisseria Gonorrhoeae DNA Diagnostic Kit

    Brief

    Chlamydia Trachomatis/Ureaplasma Urealyticum/Neisseria Gonorrhoeae DNA Diagnostic Kit (PCR-Fluorescence Probing) is a qualitative in vitro test for simultaneous detection of Chlamydia Trachomatis, Ureaplasma Urealyticum and Neisseria Gonorrhoeae DNA in sterile calcium alginate swab specimens from male urinary tract secretion and female genital tract secretion by applying real-time fluorescence quantitative PCR technique, which can provide molecular diagnosis evidence for the early diagnosis of related sexually transmitted diseases and initial screening of high-risk STD population.

    Parameters

    Product features Parameters
    Specimen Type genital tract secretions.
    Technical Platform One-tube fast release technology Advanced magnetic beads technology
    Target pathogen CT, UU, NG-DNA
    Internal Control β--globin gene
    PCR Instruments ABI7500,SLAN-96P
    Amplification Time 70 min
    Sensitivity 400 copies/mL
    Spec. 48T
    Qualification CE
  • S3018E TB – Mycobacterium Tuberculosis DNA Fluorescence Diagnostic Kit

    Brief

    Mycobacterium tuberculosis virus (TB) is a pathogenic bacterium that causes tuberculosis. It is likely to infect all human tissues and organs, especially the lungs to cause pulmonary tuberculosis. Early diagnosis and treatment are important for effective control of tuberculosis.   In recent years, with the development of molecular biology, nucleic acid fluorescence quantitative PCR method based on the mycobacterium tuberculosis nucleic acid has drawn more and more attention from researchers.

    Parameters

    Product features Parameter
    Specimen Type Human sputum
    Extraction Platform One-tube fast release technology
    Internal Control Cloning plasmid, without TB target sequence
    PCR Instrument ABI 7500, SLAN-96P,MA-6000, Stratagene Mx3000P, iPonatic S-Q31A&B,S-Q36A
    Sensitivity 1 bacterium/mL
    Spec. 48T, 12-P
    Qualification CE
  • S3122E SC2 Mut2 – SARS-CoV-2 Mutation Nucleic Acid Diagnostic Kit

    Brief

    The SARS-CoV-2 Mutation Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used to identify whether the virus contains mutation sites N501Y and HV 69-70del in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluids, saliva and sputum from patients who have been diagnosed with SARS-CoV-2 infection.

    Performance

    • ARMS-PCR: Accurate detection of N501Y, HV 69-70delmutation sites
    • Ultra fast: Optimize testing procedures, amplification time only 60min
    • High sensitivity: Detection sensitivity reaches 200 copies/mL
    • Internal control: Rnase P, Monitor the whole process (Sampling, Extraction and Amplification )

    Parameters

    Product features Parameters
    Specimen Type Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum
    Extraction Platform One-tube fast release technology / Advanced magnetic beads technology
    Target Genes N501Y, HV 69-70del, N gene
    Internal Control Rnase P gene
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5
    Sensitivity 200copies/mL
    Spec. 24T/48T
    Qualification CE
  • S3124E SC2 Mut5 – Detection Kit for 5 Mutations of SARS-CoV-2

    Brief

    Detection Kit for 5 Mutations of SARS-CoV-2, detects 5 SARS-CoV-2 variants, including E484K, K417N, P681H, N501Y and HV 69-70del, which covers Most Worrying Mutations.

    Performance

    • More comprehensive: Accurate detection of 5 mutation sites
    • Ultra fast: Optimize testing procedures, amplification time only 60min
    • High sensitivity: Detection sensitivity reaches 200 copies/mL
    • Internal control: Rnase P, Monitor the whole process

    Parameters

    Product features Parameters
    Specimen Type Oropharyngeal swab, sputum, alveolar lavage fluid, nasopharyngeal swab and saliva
    Extraction Platform Advanced magnetic beads technology
    Target Genes E484K, K417N, P681H, N501Y, HV 69-70del, N gene
    Internal Control Rnase P
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5
    Sensitivity 200copies/mL
    Spec. 24T/48T
    Qualification CE
  • S3113E SC2/FluA/B – SARS-CoV-2 and Influenza A/B Virus Nucleic Acid Diagnostic Kit

    Brief

    Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.   Sansure COVID-19 diagnostic solutions are used to directly detect  the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness. This kit can also joint-detect RNA of influenza A virus and influenza B virus.

    Parameters

    Product features Parameters
    Specimen Type Oropharyngeal swab, sputum
    Extraction Platform One-tube fast release technology Advanced magnetic beads technology
    Target Genes SARS-CoV-2:ORF 1ab, N gene; influenza A:M gene; influenza B:NP gene
    Internal Control Rnase P gene
    PCR Instrument ABI7500, SLAN-96P, MA-6000, QuantGene 9600, iPonatic S-Q31A&B,S-Q36A
    Sensitivity 200 copies/mL
    Spec. 24T, 48T, 24-P
    Qualification CE
×
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.
SUBMIT

Thank you!

We shall contact you soon!
Back Top